Sun.Dec 10, 2023

article thumbnail

Golidocitinib Demonstrates Significant Survival Benefits For Patients with Peripheral T-cell Lymphoma

Pharmacy Times

Median overall survival is set to be more than 2 years, which is more than double the overall survival of current frontline therapies.

144
144
article thumbnail

Driven by demand, growth in autism, IDD care at all-time high, CentralReach report finds

Fierce Healthcare

Growth in autism and intellectual & developmental disability (IDD) services is at an all-time high, according to | Autism services grew 49% year-over-year between Q1 and Q3 2023, compared to the same period in 2022. Demand is likely on an upward trajectory, the report predicted.

122
122
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

ASH President Speaks on Pharmacists, Novel Innovations in Hematology

Pharmacy Times

He also provides insight for students training in classical hematology, oncology hematology, or oncology pharmacy.

131
131
article thumbnail

Clonidine Versus Guanfacine: ADHD Management

Med Ed 101

This article will discuss two of the three commonly used non-stimulant medications for the management of ADHD and ADHD-related symptoms. We will primarily focus on comparing clonidine versus guanfacine in pediatric patients. As pharmacies deal with shortages of more and more stimulant medications commonly used to treat ADHD in children, it may come up more […] The post Clonidine Versus Guanfacine: ADHD Management appeared first on Med Ed 101.

105
105
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Gender Gap in NIH-Awarded Research Grants Persists in the Field of Non-Malignant Hematology

Pharmacy Times

The study results shine a light on the potential need for further policy changes that promote gender equity and bridge the gap in R01 funding awarded to female applicants.

129
129
article thumbnail

ASH: Roche offers glimpse of Columvi-Polivy combo's early lymphoma data as phase 3 kicks off

Fierce Pharma

Roche’s blood cancer portfolio is booming with new life thanks to the antibody-drug conjugate Polivy and bispecifics. | As Roche’s blood cancer portfolio booms with new life thanks to the antibody-drug conjugate Polivy and bispecifics, the company is offering a look at data for two combinations of those drugs that support two phase 3 trials in diffuse large B-cell lymphoma.

102
102

More Trending

article thumbnail

Pharmaceutical Executive: December 2023 Issue (PDF)

PharmExec

Click the title above for a link to open the Pharmaceutical Executive November 2023 issue in an interactive PDF format.

52
article thumbnail

Chemist Warehouse merger with Sigma to create $8.8bn pharmacy group

The Guardian - Pharmaceutical Industry

Proposed merger with smaller competitor Sigma and stock market listing would unlock billions of dollars for founders of discount pharmacy chain Chemist Warehouse Follow our Australia news live blog for latest updates Get our morning and afternoon news emails , free app or daily news podcast Chemist Warehouse will become a publicly traded company through a merger with Sigma Healthcare, creating a retailing giant and unlocking billions of dollars for the founders of the discount pharmacy chain.

49
article thumbnail

Reflecting on 2023

PharmExec

Another year in the books.

52
article thumbnail

Magnetic CPAP Masks: A Growing Concern for Patient Safety

Roots Analysis

ResMed has sold millions of magnetic CPAP masks since 2014 and received only five reports of serious harm related to the magnets, which were reported to authorities. Introduction to Magnetic CPAP Masks The medical devices domain is facing a wave of safety concerns as ResMed, a prominent manufacturer of continuous positive airway pressure (CPAP) machines, issues an urgent field safety notice regarding its magnetic masks.

FDA 45
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Hisamitsu Pharmaceutical sees highest patent filings and grants during September in Q3 2023

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for Hisamitsu Pharmaceutical here.

40
article thumbnail

Unraveling the Mystery: A Comprehensive Guide to the Science, Safety, and Secrets of Keto Gummies and Weight Loss Gummies

Roots Analysis

Introduction In the ever-evolving landscape of weight loss solutions, keto gummies and weight loss gummies have emerged as tantalizing options, promising to revolutionize the journey to a healthier, slimmer self. As the hype around these supplements continues to build, the pressing questions on everyone’s minds are: Do they really work, and are they safe?

FDA 40
article thumbnail

Lupin sees highest patent filings and grants during September in Q3 2023

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for Lupin here.

40
article thumbnail

Unveiling the Future: A Breakthrough Blood Test for Early Alzheimer’s Detection

Roots Analysis

Introduction In the ever-evolving landscape of medical advancements, a groundbreaking study conducted by Resonant, a Utah-based biotech company specializing in diagnostic tests for neurodegenerative diseases, is developing an Alzheimer’s blood test, a potential game-changer in the early detection of Alzheimer’s disease. The research suggests that a simple blood test could be the key to identifying Alzheimer’s several years before symptoms surface, offering a glimmer of hope for milli

FDA 40
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Otsuka sees highest patent filings and grants during July in Q3 2023

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for Otsuka here.

40
article thumbnail

Aya Healthcare’s Strategic Acquisition of Winnow AI: A Game-Changer in Healthcare Recruitment

Roots Analysis

Aya Healthcare strengthens its physician recruitment technology by acquiring Winnow AI, a move aimed at boosting its capabilities in the digital staffing sector. In a significant move poised to revolutionize healthcare recruitment, Aya Healthcare, a leading healthcare staffing and workforce solutions provider, has successfully acquired Winnow AI. The acquisition marks a strategic partnership between Aya Healthcare and SwitchPoint Ventures, the creator of Winnow AI, an innovative artificial intel

40
article thumbnail

Cosmo Pharmaceuticals sees highest patent filings and grants during August in Q3 2023

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for Cosmo Pharmaceuticals here.

40
article thumbnail

Novo Nordisk’s Pioneering Endeavor: Unraveling the Complexities of Obesity to Forge a Preventive Pathway

Roots Analysis

Novo Nordisk aims to employ insights from obesity drug research to proactively hinder the occurrence of weight gain. Introduction Novo Nordisk, the eminent Danish pharmaceutical giant, has embarked on a groundbreaking journey. While the demand for Novo Nordisk’s weight-loss and diabetes drugs has already propelled the company to the status of Europe’s largest, it now seeks to revolutionize the paradigm by preventing weight gain itself.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Daewoong sees highest patent filings and grants during July in Q3 2023

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for Daewoong here.

40
article thumbnail

Almirall sees highest patent filings and grants during August in Q3 2023

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for Almirall here.

40
article thumbnail

United Laboratories International sees highest patent filings and grants during July in Q3 2023

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for United Laboratories International here.

40
article thumbnail

Cipla sees highest patent filings and grants during September in Q3 2023

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for Cipla here.

40
article thumbnail

Sun Pharmaceutical Industries sees highest patent filings and grants during August in Q3 2023

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for Sun Pharmaceutical Industries here.

40